Nxstage Medical (NXTM) Reports In-Line Q1 EPS

May 9, 2017 8:22 AM EDT

Nxstage Medical (NASDAQ: NXTM) reported Q1 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $96.8 million versus the consensus estimate of $95.29 million.

For earnings history and earnings-related data on Nxstage Medical (NXTM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings